Subclinical Hypothyroidism: A Prospective Observational Study from Southern India

Area of Science:

• Pediatric Endocrinology
• Thyroid Disorders
• Clinical Research

Background:

• Subclinical hypothyroidism (SCH) is a common endocrine disorder in children.
• Understanding its natural history and predictors of progression is crucial for effective management.
• Early identification of risk factors can prevent the development of overt hypothyroidism.

Purpose of the Study:

• To evaluate the natural course of subclinical hypothyroidism in pediatric patients.
• To identify factors predicting the evolution from subclinical to overt hypothyroidism.
• To inform clinical follow-up strategies for children with SCH.

Main Methods:

• A longitudinal study was conducted on 40 children (aged 2-16 years) with SCH.
• Participants were monitored over one year with 3-monthly thyroid function tests.
• Thyroxine treatment was initiated for patients with overt hypothyroidism or thyroid stimulating hormone (TSH) levels ≥15 mIU/mL.

Main Results:

• At study conclusion, 7.5% progressed to overt hypothyroidism, 40% remained with SCH, and 52.5% became euthyroid.
• Baseline evidence of autoimmunity was a significant risk factor (P<0.05) for progression.
• TSH levels up to 15 mIU/L did not necessitate immediate treatment.

Conclusions:

• Pediatric subclinical hypothyroidism, particularly with TSH ≤15 mIU/L, warrants periodic clinical and biochemical monitoring.
• Thyroid autoimmunity is an important indicator of increased risk for progression to overt hypothyroidism.
• Management should be individualized based on TSH levels and autoimmune status.